Fabio
5.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Naloxone; possession and administration, employee or person acting on behalf of a public place. | Naloxone; possession and administration; employeeor person acting on behalf of a public place. Provides that anemployee or other person acting on behalf of a public place who hascompleted a training program on the administration of naloxone orother opioid antagonist may possess and administer naloxone or otheropioid antagonist, other than naloxone in an injectable formulationwith a hypodermic needle or syringe, in accordance with protocolsdeveloped by the Board of Pharmacy in consultation with the Boardof Medicine and the Department of Health. The bill defines "publicplace" as any enclosed area that is used or held out for use by thepublic, whether owned or operated by a public or private interest. | us/states/va | Virginia General Assembly | 2020 | SB 836 | Virginia SB 836 (2020) |
|
enacted |
|
3 | 24 | 6 | 2020-01-08 | 2020-03-11 | openstates | ocd-bill/1793799e-e8d3-4611-9943-21013665221c | https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+SB836 | 180d248818cc4a40307b4e1296ae7a7a4719cbf02edbda8ff3bf6ed0a5bb04ce | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 836 (2020) — Naloxone; possession and administration, employee or person acting on behalf of a public place.
Naloxone; possession and administration; employeeor person acting on behalf of a public place. Provides that anemployee or other person acting on behalf of a public place who hascompleted a training program on the administration of naloxone orother opioid antagonist may possess and administer naloxone or otheropioid antagonist, other than naloxone in an injectable formulationwith a hypodermic needle or syringe, in accordance with protocolsdeveloped by the Board of Pharmacy in consultation with the Boardof Medicine and the Department of Health. The bill defines "publicplace" as any enclosed area that is used or held out for use by thepublic, whether owned or operated by a public or private interest.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Acts of Assembly Chapter text (CHAP0302) (committee substitute) — source
- Bill text as passed Senate and House (SB836ER) (committee substitute) — source
- Impact statement from DPB (SB836) (committee substitute) — source
Votes
- VOTE: Block Vote Passage (98-Y 0-N) — 97–0 (pass) · lower
- Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
- Reported from Education and Health (15-Y 0-N) — 15–0 (pass) · upper
- Passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
- Reported from Health, Welfare and Institutions (22-Y 0-N) — 22–0 (pass) · lower
Sponsors
- David R. Suetterlein — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2020-01-08 Prefiled and ordered printed; offered 01/08/20 20104831D
introduction - 2020-01-08 Referred to Committee on Education and Health
referral-committee - 2020-01-16 Impact statement from DPB (SB836)
- 2020-01-27 Assigned Education sub: Health Professions
referral-committee - 2020-02-06 Reported from Education and Health (15-Y 0-N)
committee-passage - 2020-02-07 Constitutional reading dispensed (37-Y 0-N)
- 2020-02-10 Read second time and engrossed
reading-2 - 2020-02-10 Constitutional reading dispensed (39-Y 0-N)
- 2020-02-10 Passed Senate (39-Y 0-N)
passage - 2020-02-13 Placed on Calendar
- 2020-02-13 Read first time
reading-1 - 2020-02-13 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2020-02-18 Reported from Health, Welfare and Institutions (22-Y 0-N)
committee-passage - 2020-02-20 Read second time
reading-2 - 2020-02-21 Read third time
reading-3 - 2020-02-21 Passed House BLOCK VOTE (98-Y 0-N)
passage - 2020-02-21 VOTE: Block Vote Passage (98-Y 0-N)
- 2020-02-26 Enrolled
- 2020-02-26 Impact statement from DPB (SB836ER)
- 2020-02-27 Signed by President
- 2020-02-27 Signed by Speaker
- 2020-03-04 Enrolled Bill Communicated to Governor on March 4, 2020
- 2020-03-04 Governor's Action Deadline 11:59 p.m., March 11, 2020
- 2020-03-11 Approved by Governor-Chapter 302 (effective 7/1/20)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1793799e-e8d3-4611-9943-21013665221c. Confidence: reported (aggregated from official Virginia legislature records).